150 related articles for article (PubMed ID: 15494522)
1. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.
Haas PJ; de Haas CJ; Kleibeuker W; Poppelier MJ; van Kessel KP; Kruijtzer JA; Liskamp RM; van Strijp JA
J Immunol; 2004 Nov; 173(9):5704-11. PubMed ID: 15494522
[TBL] [Abstract][Full Text] [Related]
2. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
Haas PJ; de Haas CJ; Poppelier MJ; van Kessel KP; van Strijp JA; Dijkstra K; Scheek RM; Fan H; Kruijtzer JA; Liskamp RM; Kemmink J
J Mol Biol; 2005 Nov; 353(4):859-72. PubMed ID: 16213522
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.
Postma B; Poppelier MJ; van Galen JC; Prossnitz ER; van Strijp JA; de Haas CJ; van Kessel KP
J Immunol; 2004 Jun; 172(11):6994-7001. PubMed ID: 15153520
[TBL] [Abstract][Full Text] [Related]
4. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.
Wright AJ; Higginbottom A; Philippe D; Upadhyay A; Bagby S; Read RC; Monk PN; Partridge LJ
Mol Immunol; 2007 Apr; 44(10):2507-17. PubMed ID: 17258808
[TBL] [Abstract][Full Text] [Related]
6. Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus.
Gustafsson E; Haas PJ; Walse B; Hijnen M; Furebring C; Ohlin M; van Strijp JA; van Kessel KP
BMC Immunol; 2009 Mar; 10():13. PubMed ID: 19284584
[TBL] [Abstract][Full Text] [Related]
7. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
Postma B; Kleibeuker W; Poppelier MJ; Boonstra M; Van Kessel KP; Van Strijp JA; de Haas CJ
J Biol Chem; 2005 Jan; 280(3):2020-7. PubMed ID: 15542591
[TBL] [Abstract][Full Text] [Related]
8. Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies.
Gustafsson E; Rosén A; Barchan K; van Kessel KP; Haraldsson K; Lindman S; Forsberg C; Ljung L; Bryder K; Walse B; Haas PJ; van Strijp JA; Furebring C
Protein Eng Des Sel; 2010 Feb; 23(2):91-101. PubMed ID: 19959567
[TBL] [Abstract][Full Text] [Related]
9. Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.
Ippel JH; de Haas CJ; Bunschoten A; van Strijp JA; Kruijtzer JA; Liskamp RM; Kemmink J
J Biol Chem; 2009 May; 284(18):12363-72. PubMed ID: 19251703
[TBL] [Abstract][Full Text] [Related]
10. Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.
Nikiforovich GV; Baranski TJ
Biochem Biophys Res Commun; 2009 Dec; 390(3):481-4. PubMed ID: 19799858
[TBL] [Abstract][Full Text] [Related]
11. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
Mery L; Boulay F
J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
[TBL] [Abstract][Full Text] [Related]
12. A peptide mimic of the chemotaxis inhibitory protein of Staphylococcus aureus: towards the development of novel anti-inflammatory compounds.
Bunschoten A; Ippel JH; Kruijtzer JA; Feitsma L; de Haas CJ; Liskamp RM; Kemmink J
Amino Acids; 2011 Feb; 40(2):731-40. PubMed ID: 20683629
[TBL] [Abstract][Full Text] [Related]
13. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview.
Rabiet MJ; Huet E; Boulay F
Biochimie; 2007 Sep; 89(9):1089-106. PubMed ID: 17428601
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.
Liu ZJ; Yang YJ; Jiang L; Xu YC; Wang AX; Du GH; Gao JM
Acta Pharmacol Sin; 2011 Aug; 32(8):1038-44. PubMed ID: 21706042
[TBL] [Abstract][Full Text] [Related]
15. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
Suvorova ES; Gripentrog JM; Miettinen HM
Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
[TBL] [Abstract][Full Text] [Related]
16. A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
Prat C; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
J Immunol; 2006 Dec; 177(11):8017-26. PubMed ID: 17114475
[TBL] [Abstract][Full Text] [Related]
17. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
Tardif M; Mery L; Brouchon L; Boulay F
J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
[TBL] [Abstract][Full Text] [Related]
18. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
19. Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus.
Mader D; Rabiet MJ; Boulay F; Peschel A
Microbes Infect; 2010 May; 12(5):415-9. PubMed ID: 20156579
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships of human C5a and C5aR.
Huber-Lang MS; Sarma JV; McGuire SR; Lu KT; Padgaonkar VA; Younkin EM; Guo RF; Weber CH; Zuiderweg ER; Zetoune FS; Ward PA
J Immunol; 2003 Jun; 170(12):6115-24. PubMed ID: 12794141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
